Giant Cell Arteritis: From Pathogenesis to Therapeutic Management.
作者信息
Watanabe Ryu, Goronzy Jörg J, Berry Gerald, Liao Y Joyce, Weyand Cornelia M
机构信息
Division of Immunology and Rheumatology, Department of Medicine, Stanford University School of Medicine, Stanford, CA.
Department of Pathology, Stanford University School of Medicine, Stanford, CA.
出版信息
Curr Treatm Opt Rheumatol. 2016 Jun;2(2):126-137. doi: 10.1007/s40674-016-0043-x. Epub 2016 Apr 11.
Abstract
摘要
相似文献
1
Giant Cell Arteritis: From Pathogenesis to Therapeutic Management.
Curr Treatm Opt Rheumatol. 2016 Jun;2(2):126-137. doi: 10.1007/s40674-016-0043-x. Epub 2016 Apr 11.
2
[Pathophysiology of giant cell arteritis].
Rev Med Interne. 2013 Jul;34(7):392-402. doi: 10.1016/j.revmed.2013.02.037. Epub 2013 Mar 23.
3
Recent advances in our understanding of giant cell arteritis pathogenesis.
Autoimmun Rev. 2017 Aug;16(8):833-844. doi: 10.1016/j.autrev.2017.05.014. Epub 2017 May 28.
4
[Giant cell arteritis (temporal arteritis). Pathophysiology, immunology].
Ophthalmologe. 2006 Apr;103(4):302-7. doi: 10.1007/s00347-006-1327-6.
5
[Giant-cell arteritis pathogenesis].
Presse Med. 2012 Oct;41(10):937-47. doi: 10.1016/j.lpm.2012.07.005. Epub 2012 Aug 14.
6
Pathogenesis of giant cell arteritis: More than just an inflammatory condition?
Autoimmun Rev. 2010 Aug;9(10):635-45. doi: 10.1016/j.autrev.2010.05.002. Epub 2010 May 8.
7
The activation pattern of macrophages in giant cell (temporal) arteritis and primary angiitis of the central nervous system.
Neuropathology. 2014 Jun;34(3):236-42. doi: 10.1111/neup.12086. Epub 2013 Dec 20.
8
Difference in immunohistochemical characteristics between Takayasu arteritis and giant cell arteritis: It may be better to distinguish them in the same age.
Mod Rheumatol. 2019 Nov;29(6):992-1001. doi: 10.1080/14397595.2019.1570999. Epub 2019 Feb 18.
9
Functional profile of tissue-infiltrating and circulating CD68+ cells in giant cell arteritis. Evidence for two components of the disease.
J Clin Invest. 1994 Sep;94(3):1134-40. doi: 10.1172/JCI117428.
10
Pathogenesis of giant cell arteritis: new insight into the implication of CD161+ T cells.
Clin Exp Rheumatol. 2013 Jan-Feb;31(1 Suppl 75):S65-73. Epub 2013 Apr 19.
引用本文的文献
1
Signal Regulatory Protein α Expression in Systemic Vasculitis.
ACR Open Rheumatol. 2024 Oct;6(10):634-640. doi: 10.1002/acr2.11716. Epub 2024 Jul 15.
2
Concomitant Polymyalgia Rheumatica and Giant Cell Arteritis Associated with Cystic Echinococcosis: A Rare Geriatric Case.
Acta Parasitol. 2024 Mar;69(1):1085-1089. doi: 10.1007/s11686-024-00824-z. Epub 2024 Mar 7.
3
Rheumatic Immune-Related Adverse Events due to Immune Checkpoint Inhibitors-A 2023 Update.
Int J Mol Sci. 2023 Mar 15;24(6):5643. doi: 10.3390/ijms24065643.
4
Pathogenic role of monocytes/macrophages in large vessel vasculitis.
Front Immunol. 2022 Jul 29;13:859502. doi: 10.3389/fimmu.2022.859502. eCollection 2022.
5
Tocilizumab in visual involvement of giant cell arteritis: a multicenter study of 471 patients.
Ther Adv Musculoskelet Dis. 2022 Jul 22;14:1759720X221113747. doi: 10.1177/1759720X221113747. eCollection 2022.
6
Vasculitogenic T Cells in Large Vessel Vasculitis.
Front Immunol. 2022 Jun 15;13:923582. doi: 10.3389/fimmu.2022.923582. eCollection 2022.
7
Looking ahead: giant-cell arteritis in 10 years time.
Ther Adv Musculoskelet Dis. 2022 May 24;14:1759720X221096366. doi: 10.1177/1759720X221096366. eCollection 2022.
8
Dysregulated Expression of Arterial MicroRNAs and Their Target Gene Networks in Temporal Arteries of Treatment-Naïve Patients with Giant Cell Arteritis.
Int J Mol Sci. 2021 Jun 17;22(12):6520. doi: 10.3390/ijms22126520.
9
A Review of the Dermatological Complications of Giant Cell Arteritis.
Clin Cosmet Investig Dermatol. 2021 Mar 25;14:303-312. doi: 10.2147/CCID.S284795. eCollection 2021.
10
Somatic Mutations and the Risk of Undifferentiated Autoinflammatory Disease in MDS: An Under-Recognized but Prognostically Important Complication.
Front Immunol. 2021 Feb 19;12:610019. doi: 10.3389/fimmu.2021.610019. eCollection 2021.
本文引用的文献
1
Blocking interferon γ reduces expression of chemokines CXCL9, CXCL10 and CXCL11 and decreases macrophage infiltration in ex vivo cultured arteries from patients with giant cell arteritis.
Ann Rheum Dis. 2016 Jun;75(6):1177-86. doi: 10.1136/annrheumdis-2015-208371. Epub 2015 Dec 23.
2
Prevalence and distribution of VZV in temporal arteries of patients with giant cell arteritis.
Neurology. 2015 Nov 24;85(21):1914-5. doi: 10.1212/01.wnl.0000475335.63503.86.
3
Regulation of Inflammation and Angiogenesis in Giant Cell Arteritis by Acute-Phase Serum Amyloid A.
Arthritis Rheumatol. 2015 Sep;67(9):2447-56. doi: 10.1002/art.39217.
4
Difference in the expression of IL-9 and IL-17 correlates with different histological pattern of vascular wall injury in giant cell arteritis.
Rheumatology (Oxford). 2015 Sep;54(9):1596-604. doi: 10.1093/rheumatology/kev102. Epub 2015 Apr 9.
5
The development and in vivo function of T helper 9 cells.
Nat Rev Immunol. 2015 May;15(5):295-307. doi: 10.1038/nri3824. Epub 2015 Apr 7.
6
Macrophages in vascular inflammation--From atherosclerosis to vasculitis.
Autoimmunity. 2015 May;48(3):139-51. doi: 10.3109/08916934.2015.1027815. Epub 2015 Mar 26.
7
Serum markers associated with disease activity in giant cell arteritis and polymyalgia rheumatica.
Rheumatology (Oxford). 2015 Aug;54(8):1397-402. doi: 10.1093/rheumatology/keu526. Epub 2015 Feb 26.
8
Interleukin-22: immunobiology and pathology.
Annu Rev Immunol. 2015;33:747-85. doi: 10.1146/annurev-immunol-032414-112123. Epub 2015 Feb 11.
9
T cell subsets and their signature cytokines in autoimmune and inflammatory diseases.
Cytokine. 2015 Jul;74(1):5-17. doi: 10.1016/j.cyto.2014.09.011. Epub 2014 Oct 30.
10
Neurotrophins are expressed in giant cell arteritis lesions and may contribute to vascular remodeling.
Arthritis Res Ther. 2014 Nov 24;16(6):487. doi: 10.1186/s13075-014-0487-z.
Zotero 插件